Drug is promising against pancreatic and breast cancers
ProAgio, a drug developed by Georgia State University (USA) biology professor Zhi-Ren Liu and his…
Browsing: Pancreatic Cancer
New biomarker may predict which pancreatic cancer patients respond to CD40 immunotherapy
Inflammation in the blood could serve as a new biomarker to help identify patients with…
Human pancreatic cancer model offers new opportunities for testing drugs
UNSW scientists have grown human pancreatic cancer tumours in the lab—their model is the first…
How genes and environment conspire in pancreatic cancer development discovered
Like weeds sprouting from cracks in the pavement, cancer often forms in sites of tissue…
Mechanism for how pancreatic cancer evades immunotherapy elucidated
Pancreatic cancer, one of the most lethal of all cancers, is capable of evading attacks…
Pre-surgery chemotherapy is possible for early stage pancreatic cancer patients
A first-of-its-kind randomised clinical trial found that patients with pancreatic cancer didn’t live any longer…
Novel target: could improve safety of therapy for pancreatic cancer
Researchers from Queen Mary University of London, UK, have identified a protein that may represent…
Encapsulating drugs in nanoparticles to target pancreatic cancer cells
Researchers with the Kansas City Veterans Affairs Medical Center and North Dakota State University, USA,…
Researchers develop a new approach to detect pancreatic cancer
A protein found commonly in human blood might help with the detection of hard-to-diagnose pancreatic…
Researchers develop virus-based treatment platform to fight pancreatic cancer
Researchers from Queen Mary University of London and Zhengzhou University have developed a powerful therapeutic…